RecruitingPhase 1NCT07267026
Ophthalmological
Macular corneal dystrophy
10
studies recruiting now
as of 7 Sept 2026
29
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
5 Dec 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT06983028
Atacicept in Multiple Glomerular Diseases
RecruitingNCT01209000
Nephrotic Syndrome Study Network
RecruitingNot applicableNCT04571658
NEPTUNE Match Study
RecruitingNCT06491615
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 10 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Macular corneal dystrophy study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Macular corneal dystrophy
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (CHST6).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).